AT
INO icon

American Trust’s Inovio Pharmaceuticals INO Stock Holding History

American Trust’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,944
Closed -$11.9K – 296
2023
Q4 		$11.9K Hold
1,944
– – ﹤0.01% 285
2023
Q3 		$9.08K Sell
1,944
-556
-22% -$3.07K ﹤0.01% 286
2023
Q2 		$13.4K Buy
2,500
+194
+8% +$1.56K ﹤0.01% 418
2023
Q1 		$22.7K Hold
2,306
– – ﹤0.01% 434
2022
Q4 		$43.2K Hold
2,306
– – ﹤0.01% 433
2022
Q3 		$48K Hold
2,306
– – ﹤0.01% 414
2022
Q2 		$48K Buy
2,306
+417
+22% +$11.8K ﹤0.01% 439
2022
Q1 		$81K Buy
1,889
+42
+2% +$1.89K 0.01% 498
2021
Q4 		$111K Buy
+1,847
New +$148K 0.01% 367

Other funds holding INO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

American Trust's INO Position: Q1 2024 in Review

American Trust sold out of Inovio Pharmaceuticals (INO) in Q1 2024, closing a stake of 1,944 shares — an estimated $11.9K sold.

American Trust first reported a position in INO in Q4 2021 and held it in 9 quarters. The position peaked at $111K in Q4 2021. 89 funds tracked by Wall St. Rank hold INO as of Q1 2024.

  • American Trust reported no remaining Inovio Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • American Trust sold 1,944 Inovio Pharmaceuticals shares in Q1 2024, an estimated $11.9K.
  • American Trust first reported a position in Inovio Pharmaceuticals in Q4 2021 and held it in 9 quarters.
  • American Trust's Inovio Pharmaceuticals position peaked at $111K in Q4 2021.
  • 89 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2024.

Based on American Trust's 13F filing for Q1 2024, filed 11 Jun 2024.